Stock Track | OPKO Health Soars 5.19% as Piper Sandler Reiterates Buy Rating

Stock Track

May 02, 2025

OPKO Health (OPK) stock is surging 5.19% in intraday trading on Friday, as investors react positively to a reaffirmed analyst rating. The healthcare company's shares are seeing significant upward momentum, outperforming the broader market.

The stock's climb comes on the heels of a report released earlier today by Piper Sandler analyst Edward Tenthoff. In his analysis, Tenthoff reiterated a Buy rating on OPKO Health, maintaining his positive outlook on the company's prospects. While the specific price target was not mentioned in the available information, the reaffirmation of the Buy rating suggests confidence in OPKO's future performance.

This bullish stance from a reputable Wall Street firm appears to be driving investor enthusiasm, leading to the notable price increase. As OPKO Health continues to navigate the competitive healthcare landscape, such positive analyst coverage could potentially attract more investor attention and support the stock's upward trajectory in the near term.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1152307320"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1152307320\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1152307320?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-02 22:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152307320","market":"nz","top_or_hot":-1,"title":"Stock Track | OPKO Health Soars 5.19% as Piper Sandler Reiterates Buy Rating","media":"Stock Track","content":"<p>OPKO Health (OPK) stock is surging 5.19% in intraday trading on Friday, as investors react positively to a reaffirmed analyst rating. The healthcare company's shares are seeing significant upward momentum, outperforming the broader market.</p>\n\n<p>The stock's climb comes on the heels of a report released earlier today by Piper Sandler analyst Edward Tenthoff. In his analysis, Tenthoff reiterated a Buy rating on OPKO Health, maintaining his positive outlook on the company's prospects. While the specific price target was not mentioned in the available information, the reaffirmation of the Buy rating suggests confidence in OPKO's future performance.</p>\n\n<p>This bullish stance from a reputable Wall Street firm appears to be driving investor enthusiasm, leading to the notable price increase. As OPKO Health continues to navigate the competitive healthcare landscape, such positive analyst coverage could potentially attract more investor attention and support the stock's upward trajectory in the near term.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | OPKO Health Soars 5.19% as Piper Sandler Reiterates Buy Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | OPKO Health Soars 5.19% as Piper Sandler Reiterates Buy Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-02 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>OPKO Health (OPK) stock is surging 5.19% in intraday trading on Friday, as investors react positively to a reaffirmed analyst rating. The healthcare company's shares are seeing significant upward momentum, outperforming the broader market.</p>\n\n<p>The stock's climb comes on the heels of a report released earlier today by Piper Sandler analyst Edward Tenthoff. In his analysis, Tenthoff reiterated a Buy rating on OPKO Health, maintaining his positive outlook on the company's prospects. While the specific price target was not mentioned in the available information, the reaffirmation of the Buy rating suggests confidence in OPKO's future performance.</p>\n\n<p>This bullish stance from a reputable Wall Street firm appears to be driving investor enthusiasm, leading to the notable price increase. As OPKO Health continues to navigate the competitive healthcare landscape, such positive analyst coverage could potentially attract more investor attention and support the stock's upward trajectory in the near term.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPK","symbol_name":"Opko Health","start_time":0,"source_url":"","article_id":"1152307320","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152307320","pubTimestamp":1746197669,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"OPKO Health  stock is surging 5.19% in intraday trading on Friday, as investors react positively to a reaffirmed analyst rating. The healthcare company's shares are seeing significant upward momentum, outperforming the broader market.The stock's climb comes on the heels of a report released earlier today by Piper Sandler analyst Edward Tenthoff. In his analysis, Tenthoff reiterated a Buy rating on OPKO Health, maintaining his positive outlook on the company's prospects. While the specific price ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OPK":"Opko Health"},"translate_title":"Piper Sandler重申买入评级，OPKO Health股价飙升5.19%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPK":1},"content_text":"OPKO Health (OPK) stock is surging 5.19% in intraday trading on Friday, as investors react positively to a reaffirmed analyst rating. The healthcare company's shares are seeing significant upward momentum, outperforming the broader market.\nThe stock's climb comes on the heels of a report released earlier today by Piper Sandler analyst Edward Tenthoff. In his analysis, Tenthoff reiterated a Buy rating on OPKO Health, maintaining his positive outlook on the company's prospects. While the specific price target was not mentioned in the available information, the reaffirmation of the Buy rating suggests confidence in OPKO's future performance.\nThis bullish stance from a reputable Wall Street firm appears to be driving investor enthusiasm, leading to the notable price increase. As OPKO Health continues to navigate the competitive healthcare landscape, such positive analyst coverage could potentially attract more investor attention and support the stock's upward trajectory in the near term.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}